The JSE was firmer on Tuesday, with global peers mixed as investors pinned hopes for economic revival on Covid-19 vaccines.

The vaccine developed by AstraZeneca and Oxford University is the third major trial to report success after US-based Moderna and Pfizer with Germany's BioNTech, sending pandemic-weary investors to take on risk in hopes of a swift economic recovery...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now